Danielle Cooke
Concepts (485)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intracranial Arteriovenous Malformations | 26 | 2022 | 50 | 6.050 |
Why?
| Embolization, Therapeutic | 28 | 2023 | 206 | 5.660 |
Why?
| Intracranial Aneurysm | 20 | 2022 | 95 | 5.420 |
Why?
| Endovascular Procedures | 22 | 2022 | 301 | 4.200 |
Why?
| Central Nervous System Vascular Malformations | 12 | 2025 | 24 | 2.360 |
Why?
| Subarachnoid Hemorrhage | 10 | 2022 | 63 | 2.350 |
Why?
| Endothelial Cells | 8 | 2022 | 740 | 2.320 |
Why?
| Cerebral Angiography | 24 | 2024 | 108 | 2.310 |
Why?
| Stents | 11 | 2022 | 504 | 2.100 |
Why?
| Stroke | 19 | 2023 | 1064 | 2.100 |
Why?
| Biopsy | 7 | 2022 | 1087 | 2.040 |
Why?
| Angiography, Digital Subtraction | 17 | 2025 | 43 | 1.910 |
Why?
| Aneurysm, Ruptured | 7 | 2022 | 34 | 1.820 |
Why?
| Arteriovenous Fistula | 8 | 2025 | 35 | 1.740 |
Why?
| Tomography, X-Ray Computed | 18 | 2022 | 2525 | 1.490 |
Why?
| Robotics | 3 | 2024 | 90 | 1.470 |
Why?
| Brain Ischemia | 10 | 2022 | 316 | 1.200 |
Why?
| Intracranial Hemorrhages | 7 | 2022 | 80 | 1.200 |
Why?
| Basilar Artery | 2 | 2018 | 6 | 1.170 |
Why?
| Retinoblastoma | 5 | 2023 | 31 | 1.120 |
Why?
| Retinal Neoplasms | 4 | 2018 | 26 | 1.080 |
Why?
| Fluoroscopy | 8 | 2018 | 156 | 1.070 |
Why?
| Vasospasm, Intracranial | 6 | 2017 | 17 | 1.070 |
Why?
| Feasibility Studies | 6 | 2022 | 864 | 1.030 |
Why?
| Neurosurgery | 2 | 2022 | 37 | 0.920 |
Why?
| Humans | 141 | 2025 | 129212 | 0.890 |
Why?
| Iliac Artery | 2 | 2014 | 56 | 0.880 |
Why?
| Magnetic Resonance Imaging | 20 | 2025 | 3390 | 0.870 |
Why?
| Phantoms, Imaging | 6 | 2018 | 137 | 0.860 |
Why?
| Radiography, Interventional | 5 | 2023 | 105 | 0.860 |
Why?
| Magnetic Resonance Imaging, Interventional | 6 | 2016 | 23 | 0.840 |
Why?
| Endothelium, Vascular | 3 | 2019 | 898 | 0.830 |
Why?
| Vascular Malformations | 5 | 2022 | 50 | 0.830 |
Why?
| Radiosurgery | 8 | 2022 | 319 | 0.820 |
Why?
| Thrombectomy | 8 | 2022 | 59 | 0.810 |
Why?
| Cerebral Hemorrhage | 7 | 2022 | 107 | 0.810 |
Why?
| Software | 4 | 2020 | 607 | 0.800 |
Why?
| Stroke Rehabilitation | 1 | 2023 | 40 | 0.800 |
Why?
| Aneurysm | 3 | 2021 | 29 | 0.800 |
Why?
| Retrospective Studies | 55 | 2025 | 14488 | 0.780 |
Why?
| Brain | 16 | 2025 | 2664 | 0.740 |
Why?
| Middle Aged | 58 | 2025 | 31075 | 0.730 |
Why?
| Carotid Stenosis | 1 | 2022 | 84 | 0.730 |
Why?
| Cerebral Arteries | 4 | 2017 | 60 | 0.710 |
Why?
| Male | 79 | 2025 | 63491 | 0.710 |
Why?
| Magnetic Resonance Angiography | 6 | 2020 | 235 | 0.700 |
Why?
| Balloon Occlusion | 1 | 2020 | 34 | 0.680 |
Why?
| Neuroimaging | 6 | 2025 | 279 | 0.680 |
Why?
| Central Nervous System Diseases | 1 | 2021 | 67 | 0.670 |
Why?
| Veins | 3 | 2022 | 60 | 0.670 |
Why?
| Vascular Access Devices | 3 | 2018 | 26 | 0.670 |
Why?
| Carotid Artery, Common | 1 | 2020 | 35 | 0.660 |
Why?
| Robotic Surgical Procedures | 1 | 2021 | 109 | 0.660 |
Why?
| Cerebral Veins | 3 | 2021 | 15 | 0.650 |
Why?
| Treatment Outcome | 33 | 2023 | 10189 | 0.640 |
Why?
| Melphalan | 3 | 2018 | 29 | 0.630 |
Why?
| Catheterization, Peripheral | 3 | 2016 | 104 | 0.630 |
Why?
| Needles | 2 | 2018 | 56 | 0.610 |
Why?
| Arteriovenous Shunt, Surgical | 1 | 2018 | 16 | 0.600 |
Why?
| Graft Occlusion, Vascular | 1 | 2018 | 41 | 0.590 |
Why?
| Wounds, Stab | 1 | 2018 | 12 | 0.590 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2022 | 440 | 0.590 |
Why?
| Female | 77 | 2025 | 68600 | 0.590 |
Why?
| Aged | 45 | 2025 | 22030 | 0.580 |
Why?
| Jugular Veins | 1 | 2018 | 40 | 0.580 |
Why?
| Neck Injuries | 1 | 2018 | 20 | 0.570 |
Why?
| Nerve Net | 5 | 2020 | 259 | 0.560 |
Why?
| Aorta, Thoracic | 1 | 2020 | 262 | 0.560 |
Why?
| Obsessive-Compulsive Disorder | 3 | 2023 | 44 | 0.550 |
Why?
| Lymphatic Abnormalities | 3 | 2022 | 19 | 0.540 |
Why?
| Adult | 47 | 2025 | 35464 | 0.510 |
Why?
| Angioplasty | 3 | 2022 | 47 | 0.490 |
Why?
| Orbital Diseases | 2 | 2018 | 28 | 0.480 |
Why?
| Vertebrobasilar Insufficiency | 1 | 2015 | 8 | 0.480 |
Why?
| Disease Management | 3 | 2017 | 586 | 0.480 |
Why?
| Tissue and Organ Harvesting | 1 | 2015 | 72 | 0.450 |
Why?
| Renal Dialysis | 1 | 2018 | 423 | 0.450 |
Why?
| Spinal Cord | 4 | 2025 | 356 | 0.450 |
Why?
| Magnetic Fields | 2 | 2014 | 22 | 0.440 |
Why?
| Neural Pathways | 4 | 2020 | 302 | 0.440 |
Why?
| Image Interpretation, Computer-Assisted | 2 | 2020 | 253 | 0.440 |
Why?
| Deep Brain Stimulation | 1 | 2015 | 125 | 0.420 |
Why?
| Mammary Arteries | 1 | 2012 | 7 | 0.400 |
Why?
| Cell Separation | 1 | 2013 | 316 | 0.400 |
Why?
| Transcranial Magnetic Stimulation | 3 | 2020 | 57 | 0.400 |
Why?
| Infusions, Intra-Arterial | 6 | 2018 | 53 | 0.400 |
Why?
| Clinical Protocols | 3 | 2018 | 254 | 0.390 |
Why?
| Infarction, Middle Cerebral Artery | 2 | 2013 | 38 | 0.390 |
Why?
| Blood Vessel Prosthesis | 3 | 2019 | 124 | 0.390 |
Why?
| Vertebral Artery Dissection | 1 | 2012 | 25 | 0.390 |
Why?
| Brain Neoplasms | 2 | 2025 | 1170 | 0.390 |
Why?
| Catheters | 4 | 2017 | 68 | 0.380 |
Why?
| Sclerotherapy | 4 | 2022 | 19 | 0.370 |
Why?
| Proto-Oncogene Proteins p21(ras) | 3 | 2021 | 259 | 0.360 |
Why?
| Radial Artery | 2 | 2021 | 69 | 0.360 |
Why?
| Temporal Arteries | 1 | 2011 | 45 | 0.360 |
Why?
| Atherosclerosis | 1 | 2015 | 402 | 0.350 |
Why?
| Carotid Artery, Internal | 4 | 2019 | 41 | 0.350 |
Why?
| Transcriptome | 3 | 2022 | 885 | 0.350 |
Why?
| Neuronavigation | 1 | 2010 | 7 | 0.340 |
Why?
| Surgical Instruments | 1 | 2010 | 50 | 0.330 |
Why?
| Ultrasonography, Doppler, Transcranial | 4 | 2017 | 38 | 0.330 |
Why?
| Arteriovenous Malformations | 2 | 2020 | 26 | 0.320 |
Why?
| Cardiac Catheterization | 1 | 2013 | 517 | 0.320 |
Why?
| Carotid-Cavernous Sinus Fistula | 2 | 2019 | 9 | 0.320 |
Why?
| MAP Kinase Signaling System | 2 | 2021 | 311 | 0.320 |
Why?
| Cerebrovascular Circulation | 5 | 2022 | 223 | 0.300 |
Why?
| Connectome | 5 | 2020 | 84 | 0.300 |
Why?
| Vasodilator Agents | 1 | 2010 | 326 | 0.300 |
Why?
| Magnetics | 4 | 2016 | 44 | 0.300 |
Why?
| Ophthalmic Artery | 2 | 2018 | 5 | 0.290 |
Why?
| Foramen Magnum | 2 | 2021 | 8 | 0.290 |
Why?
| Contrast Media | 4 | 2020 | 391 | 0.290 |
Why?
| Aged, 80 and over | 12 | 2022 | 7061 | 0.290 |
Why?
| Brain Mapping | 5 | 2020 | 572 | 0.290 |
Why?
| Cerebral Revascularization | 2 | 2020 | 19 | 0.280 |
Why?
| Cohort Studies | 11 | 2023 | 5408 | 0.250 |
Why?
| Antineoplastic Agents, Alkylating | 2 | 2018 | 69 | 0.250 |
Why?
| Child | 25 | 2023 | 20853 | 0.250 |
Why?
| Sclerosing Solutions | 3 | 2022 | 10 | 0.250 |
Why?
| Preoperative Care | 3 | 2021 | 336 | 0.250 |
Why?
| Young Adult | 16 | 2025 | 12396 | 0.250 |
Why?
| Cervical Vertebrae | 2 | 2025 | 132 | 0.240 |
Why?
| Meningioma | 2 | 2016 | 81 | 0.240 |
Why?
| Embolectomy | 2 | 2017 | 13 | 0.240 |
Why?
| Risk Factors | 9 | 2022 | 9747 | 0.240 |
Why?
| Catheterization | 2 | 2017 | 175 | 0.240 |
Why?
| Intracranial Arteriosclerosis | 2 | 2014 | 7 | 0.230 |
Why?
| Infant | 13 | 2023 | 9016 | 0.230 |
Why?
| Adolescent | 23 | 2025 | 20371 | 0.230 |
Why?
| Mutation | 5 | 2021 | 3715 | 0.230 |
Why?
| Perfusion Imaging | 3 | 2022 | 56 | 0.220 |
Why?
| Mosaicism | 2 | 2021 | 71 | 0.220 |
Why?
| Imaging, Three-Dimensional | 3 | 2020 | 530 | 0.220 |
Why?
| Radiography | 4 | 2014 | 798 | 0.220 |
Why?
| Microsurgery | 2 | 2021 | 70 | 0.220 |
Why?
| Computed Tomography Angiography | 3 | 2020 | 115 | 0.210 |
Why?
| Swine | 6 | 2018 | 757 | 0.210 |
Why?
| Implosive Therapy | 1 | 2023 | 44 | 0.200 |
Why?
| Radiology, Interventional | 1 | 2023 | 30 | 0.200 |
Why?
| Neurosurgical Procedures | 5 | 2022 | 173 | 0.200 |
Why?
| Child, Preschool | 15 | 2021 | 10507 | 0.200 |
Why?
| Cerebral Cortex | 3 | 2022 | 432 | 0.200 |
Why?
| Machine Learning | 2 | 2024 | 443 | 0.200 |
Why?
| Flow Cytometry | 2 | 2017 | 1156 | 0.200 |
Why?
| Ventriculostomy | 2 | 2013 | 22 | 0.190 |
Why?
| Giant Cell Arteritis | 1 | 2022 | 47 | 0.190 |
Why?
| Polyarteritis Nodosa | 1 | 2021 | 6 | 0.190 |
Why?
| Methamphetamine | 1 | 2022 | 55 | 0.190 |
Why?
| Hematoma | 1 | 2021 | 54 | 0.180 |
Why?
| Actins | 2 | 2013 | 408 | 0.180 |
Why?
| Materials Testing | 2 | 2020 | 346 | 0.180 |
Why?
| Combined Modality Therapy | 3 | 2016 | 1202 | 0.180 |
Why?
| Precision Medicine | 1 | 2025 | 387 | 0.180 |
Why?
| Cerebrovascular Disorders | 1 | 2022 | 90 | 0.180 |
Why?
| Angioplasty, Balloon | 1 | 2022 | 91 | 0.180 |
Why?
| Iodine Compounds | 1 | 2020 | 3 | 0.180 |
Why?
| Surgery, Computer-Assisted | 2 | 2019 | 76 | 0.180 |
Why?
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2021 | 29 | 0.180 |
Why?
| Equipment Design | 5 | 2015 | 513 | 0.180 |
Why?
| Gene Expression | 2 | 2017 | 1469 | 0.180 |
Why?
| Moyamoya Disease | 1 | 2020 | 19 | 0.180 |
Why?
| Brain Infarction | 1 | 2020 | 23 | 0.180 |
Why?
| Orbit | 2 | 2011 | 57 | 0.170 |
Why?
| Growth Disorders | 1 | 2021 | 80 | 0.170 |
Why?
| Phenotype | 5 | 2021 | 3074 | 0.170 |
Why?
| Nervous System Diseases | 2 | 2021 | 252 | 0.170 |
Why?
| Observer Variation | 2 | 2020 | 314 | 0.170 |
Why?
| Recurrence | 3 | 2020 | 1005 | 0.170 |
Why?
| Tomography, Emission-Computed, Single-Photon | 2 | 2011 | 76 | 0.170 |
Why?
| Spinal Cord Diseases | 1 | 2020 | 41 | 0.170 |
Why?
| Blood Vessels | 1 | 2022 | 187 | 0.170 |
Why?
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2020 | 12 | 0.170 |
Why?
| Calcium Channel Blockers | 2 | 2022 | 159 | 0.170 |
Why?
| Models, Anatomic | 1 | 2020 | 89 | 0.170 |
Why?
| Head Injuries, Penetrating | 1 | 2020 | 5 | 0.170 |
Why?
| Multivariate Analysis | 3 | 2020 | 1500 | 0.170 |
Why?
| Unconsciousness | 1 | 2020 | 19 | 0.170 |
Why?
| Drug Administration Schedule | 1 | 2022 | 767 | 0.170 |
Why?
| Printing, Three-Dimensional | 1 | 2020 | 86 | 0.160 |
Why?
| Pyrimidinones | 1 | 2020 | 103 | 0.160 |
Why?
| Mental Health Services | 1 | 2024 | 404 | 0.160 |
Why?
| Mental Health | 2 | 2024 | 685 | 0.160 |
Why?
| Follow-Up Studies | 9 | 2021 | 4886 | 0.160 |
Why?
| Torticollis | 1 | 2019 | 12 | 0.160 |
Why?
| Amnesia | 1 | 2019 | 43 | 0.160 |
Why?
| Polyvinyls | 2 | 2016 | 19 | 0.160 |
Why?
| Cerebral Infarction | 2 | 2022 | 42 | 0.160 |
Why?
| Brain Stem | 1 | 2020 | 98 | 0.160 |
Why?
| Behavioral Symptoms | 1 | 2019 | 41 | 0.160 |
Why?
| Pitch Perception | 1 | 2019 | 9 | 0.160 |
Why?
| Electrocardiography | 3 | 1998 | 606 | 0.160 |
Why?
| Dimethyl Sulfoxide | 2 | 2016 | 41 | 0.160 |
Why?
| Reproducibility of Results | 6 | 2020 | 3067 | 0.160 |
Why?
| Blood Flow Velocity | 2 | 2017 | 404 | 0.160 |
Why?
| Models, Neurological | 1 | 2021 | 242 | 0.160 |
Why?
| Pyridones | 1 | 2020 | 158 | 0.160 |
Why?
| Postoperative Hemorrhage | 1 | 2019 | 87 | 0.150 |
Why?
| Aspirin | 1 | 2022 | 379 | 0.150 |
Why?
| Migraine Disorders | 1 | 2020 | 101 | 0.150 |
Why?
| Rabbits | 2 | 2022 | 778 | 0.150 |
Why?
| Vascular Endothelial Growth Factor A | 2 | 2019 | 527 | 0.150 |
Why?
| Vascular Patency | 1 | 2018 | 102 | 0.150 |
Why?
| Blood-Brain Barrier | 1 | 2019 | 128 | 0.150 |
Why?
| Family Health | 1 | 2019 | 197 | 0.150 |
Why?
| Plaque, Atherosclerotic | 1 | 2019 | 55 | 0.150 |
Why?
| Cell Count | 1 | 2019 | 314 | 0.150 |
Why?
| Retinal Vein | 1 | 2018 | 13 | 0.150 |
Why?
| Vascular Diseases | 1 | 2021 | 241 | 0.150 |
Why?
| Diagnosis, Differential | 3 | 2017 | 1424 | 0.140 |
Why?
| Receptor, TIE-1 | 1 | 2017 | 1 | 0.140 |
Why?
| Endoglin | 1 | 2017 | 19 | 0.140 |
Why?
| Motivation | 1 | 2022 | 545 | 0.140 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2017 | 55 | 0.140 |
Why?
| Gyrus Cinguli | 1 | 2017 | 79 | 0.140 |
Why?
| Memory | 1 | 2019 | 253 | 0.140 |
Why?
| Phlebography | 1 | 2017 | 38 | 0.140 |
Why?
| Diagnostic Errors | 1 | 2018 | 161 | 0.140 |
Why?
| von Willebrand Factor | 1 | 2017 | 70 | 0.140 |
Why?
| Cochlear Implantation | 1 | 2019 | 88 | 0.140 |
Why?
| Depression | 3 | 2022 | 1302 | 0.140 |
Why?
| Cochlear Implants | 1 | 2019 | 105 | 0.140 |
Why?
| Infant, Newborn | 8 | 2023 | 5753 | 0.140 |
Why?
| Radiographic Image Enhancement | 1 | 2017 | 53 | 0.140 |
Why?
| Retinal Diseases | 1 | 2018 | 86 | 0.140 |
Why?
| Conscious Sedation | 1 | 2017 | 84 | 0.130 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 96 | 0.130 |
Why?
| Microvessels | 1 | 2017 | 83 | 0.130 |
Why?
| Health Care Costs | 1 | 2019 | 367 | 0.130 |
Why?
| Prospective Studies | 9 | 2021 | 7103 | 0.130 |
Why?
| Cardiac Surgical Procedures | 1 | 2022 | 498 | 0.130 |
Why?
| Workflow | 1 | 2017 | 155 | 0.130 |
Why?
| Thalamus | 1 | 2017 | 94 | 0.130 |
Why?
| Quality Improvement | 1 | 2024 | 1100 | 0.130 |
Why?
| Depressive Disorder | 1 | 2019 | 365 | 0.130 |
Why?
| Meningeal Arteries | 1 | 2015 | 2 | 0.130 |
Why?
| Tantalum | 1 | 2015 | 3 | 0.130 |
Why?
| Carotid Arteries | 1 | 2017 | 196 | 0.130 |
Why?
| Ferrous Compounds | 1 | 2015 | 23 | 0.130 |
Why?
| Renal Artery | 1 | 2016 | 34 | 0.130 |
Why?
| Time-to-Treatment | 1 | 2017 | 180 | 0.130 |
Why?
| Magnets | 1 | 2015 | 19 | 0.130 |
Why?
| Telemedicine | 1 | 2024 | 787 | 0.130 |
Why?
| Hematoma, Subdural, Intracranial | 1 | 2015 | 1 | 0.120 |
Why?
| American Heart Association | 1 | 2017 | 296 | 0.120 |
Why?
| Antineoplastic Agents | 2 | 2018 | 2058 | 0.120 |
Why?
| Filtration | 1 | 2015 | 64 | 0.120 |
Why?
| Time Factors | 3 | 2022 | 6549 | 0.120 |
Why?
| Meningeal Neoplasms | 1 | 2016 | 93 | 0.120 |
Why?
| Hearing Loss | 1 | 2019 | 210 | 0.120 |
Why?
| Ferric Compounds | 1 | 2015 | 47 | 0.120 |
Why?
| Gene Expression Profiling | 2 | 2022 | 1705 | 0.120 |
Why?
| Aneurysm, False | 1 | 2015 | 47 | 0.120 |
Why?
| Hemodynamics | 2 | 2017 | 1086 | 0.120 |
Why?
| Genotype | 1 | 2020 | 1839 | 0.120 |
Why?
| Collateral Circulation | 1 | 2015 | 18 | 0.120 |
Why?
| Myocardial Infarction | 3 | 1998 | 1019 | 0.120 |
Why?
| Laser Capture Microdissection | 1 | 2014 | 24 | 0.120 |
Why?
| Intracranial Hypertension | 1 | 2015 | 37 | 0.120 |
Why?
| Biopsy, Needle | 1 | 2015 | 189 | 0.120 |
Why?
| Drug Carriers | 1 | 2015 | 118 | 0.120 |
Why?
| Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 124 | 0.120 |
Why?
| Lasers | 1 | 2015 | 132 | 0.120 |
Why?
| Prefrontal Cortex | 1 | 2017 | 305 | 0.110 |
Why?
| Vein of Galen Malformations | 1 | 2014 | 2 | 0.110 |
Why?
| Decision Making | 2 | 2021 | 849 | 0.110 |
Why?
| DNA, Complementary | 1 | 2014 | 270 | 0.110 |
Why?
| Protein Kinase Inhibitors | 1 | 2020 | 889 | 0.110 |
Why?
| Magnetic Phenomena | 1 | 2014 | 10 | 0.110 |
Why?
| Severity of Illness Index | 1 | 2022 | 2736 | 0.110 |
Why?
| Depressive Disorder, Major | 1 | 2017 | 345 | 0.110 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 331 | 0.110 |
Why?
| Recovery of Function | 1 | 2018 | 640 | 0.110 |
Why?
| Reference Values | 1 | 2015 | 793 | 0.110 |
Why?
| Cerebral Arterial Diseases | 1 | 2013 | 48 | 0.110 |
Why?
| Optical Imaging | 1 | 2014 | 56 | 0.110 |
Why?
| Prognosis | 7 | 2017 | 3791 | 0.110 |
Why?
| Equipment Failure Analysis | 1 | 2013 | 131 | 0.110 |
Why?
| Tungsten | 1 | 2013 | 30 | 0.110 |
Why?
| Artifacts | 1 | 2014 | 126 | 0.110 |
Why?
| Skin | 2 | 2017 | 721 | 0.100 |
Why?
| Alloys | 1 | 2013 | 33 | 0.100 |
Why?
| Ketones | 1 | 2013 | 47 | 0.100 |
Why?
| Neck | 2 | 2023 | 92 | 0.100 |
Why?
| Intracranial Thrombosis | 1 | 2012 | 16 | 0.100 |
Why?
| Radiation Dosage | 1 | 2014 | 153 | 0.100 |
Why?
| Comorbidity | 2 | 2014 | 1545 | 0.100 |
Why?
| Animals | 9 | 2022 | 35219 | 0.100 |
Why?
| Carboxypeptidases | 1 | 1992 | 13 | 0.100 |
Why?
| Paresis | 1 | 2012 | 30 | 0.100 |
Why?
| Aorta, Abdominal | 1 | 2012 | 43 | 0.100 |
Why?
| Zygoma | 1 | 2011 | 7 | 0.090 |
Why?
| Predictive Value of Tests | 5 | 2020 | 1944 | 0.090 |
Why?
| Proteoglycans | 1 | 1992 | 110 | 0.090 |
Why?
| Cranial Sinuses | 2 | 2021 | 13 | 0.090 |
Why?
| Serine Endopeptidases | 1 | 1992 | 118 | 0.090 |
Why?
| Cells, Cultured | 2 | 2022 | 4072 | 0.090 |
Why?
| Peptide Hydrolases | 1 | 1992 | 107 | 0.090 |
Why?
| Health Personnel | 1 | 2017 | 649 | 0.090 |
Why?
| Ethanol | 1 | 2015 | 587 | 0.090 |
Why?
| Patient Admission | 1 | 2012 | 182 | 0.090 |
Why?
| Mast Cells | 1 | 1992 | 142 | 0.090 |
Why?
| Parents | 1 | 2019 | 1306 | 0.090 |
Why?
| Hot Temperature | 1 | 2013 | 366 | 0.090 |
Why?
| Cell Survival | 1 | 2013 | 1085 | 0.090 |
Why?
| Cerebral Ventriculography | 1 | 2010 | 3 | 0.090 |
Why?
| Angiography | 3 | 2018 | 195 | 0.090 |
Why?
| Echoencephalography | 1 | 2010 | 4 | 0.080 |
Why?
| Organotechnetium Compounds | 1 | 2010 | 10 | 0.080 |
Why?
| Cerebral Ventricles | 1 | 2010 | 49 | 0.080 |
Why?
| Quality of Life | 1 | 2022 | 2693 | 0.080 |
Why?
| Emergency Medical Services | 1 | 1996 | 520 | 0.080 |
Why?
| Spinal Neoplasms | 1 | 2009 | 29 | 0.080 |
Why?
| Anxiety Disorders | 2 | 2023 | 354 | 0.080 |
Why?
| Datasets as Topic | 2 | 2020 | 109 | 0.080 |
Why?
| Psychiatric Status Rating Scales | 2 | 2024 | 529 | 0.080 |
Why?
| Muscle, Smooth, Vascular | 2 | 2022 | 443 | 0.080 |
Why?
| Gene Expression Regulation | 1 | 2018 | 2543 | 0.080 |
Why?
| Sensitivity and Specificity | 4 | 2020 | 1834 | 0.080 |
Why?
| Hydrocephalus | 1 | 2010 | 107 | 0.080 |
Why?
| Cysteine | 1 | 2010 | 194 | 0.080 |
Why?
| Image Processing, Computer-Assisted | 3 | 2019 | 742 | 0.070 |
Why?
| RNA | 1 | 2014 | 883 | 0.070 |
Why?
| Rupture | 2 | 2020 | 89 | 0.070 |
Why?
| ROC Curve | 2 | 2022 | 503 | 0.070 |
Why?
| Polyethylene Glycols | 1 | 2013 | 601 | 0.070 |
Why?
| Constriction, Pathologic | 2 | 2022 | 228 | 0.070 |
Why?
| Arteries | 2 | 2022 | 263 | 0.070 |
Why?
| Brain Injuries | 1 | 2013 | 467 | 0.070 |
Why?
| Registries | 1 | 2015 | 1886 | 0.070 |
Why?
| Electronic Health Records | 2 | 2024 | 975 | 0.070 |
Why?
| Case-Control Studies | 3 | 2019 | 3372 | 0.070 |
Why?
| Injections, Intra-Arterial | 2 | 2015 | 25 | 0.060 |
Why?
| Disease Models, Animal | 2 | 2015 | 4049 | 0.060 |
Why?
| Anxiety | 2 | 2023 | 959 | 0.060 |
Why?
| Atlases as Topic | 1 | 2025 | 10 | 0.060 |
Why?
| Regional Blood Flow | 2 | 2018 | 461 | 0.060 |
Why?
| Surveys and Questionnaires | 3 | 2022 | 5387 | 0.060 |
Why?
| Patient Health Questionnaire | 1 | 2024 | 36 | 0.060 |
Why?
| Age Distribution | 2 | 2014 | 372 | 0.060 |
Why?
| Camping | 1 | 2023 | 5 | 0.050 |
Why?
| Phobic Disorders | 1 | 2023 | 31 | 0.050 |
Why?
| Models, Animal | 2 | 2016 | 373 | 0.050 |
Why?
| Hypertension | 1 | 2012 | 1240 | 0.050 |
Why?
| Physician's Role | 1 | 2024 | 206 | 0.050 |
Why?
| Cross-Sectional Studies | 3 | 2022 | 5057 | 0.050 |
Why?
| Doxycycline | 1 | 2022 | 59 | 0.050 |
Why?
| Pericytes | 1 | 2022 | 25 | 0.050 |
Why?
| Technology | 1 | 2022 | 84 | 0.050 |
Why?
| Head | 1 | 2022 | 96 | 0.050 |
Why?
| Psychiatry | 1 | 2024 | 179 | 0.050 |
Why?
| Age Factors | 2 | 2021 | 3137 | 0.050 |
Why?
| Sodium | 1 | 2022 | 202 | 0.050 |
Why?
| Mood Disorders | 1 | 2022 | 120 | 0.050 |
Why?
| Skin Abnormalities | 1 | 2021 | 12 | 0.050 |
Why?
| Aging, Premature | 1 | 2021 | 13 | 0.050 |
Why?
| Intraoperative Period | 1 | 2021 | 53 | 0.040 |
Why?
| Delayed Diagnosis | 1 | 2021 | 79 | 0.040 |
Why?
| Intention | 1 | 2022 | 162 | 0.040 |
Why?
| Survival Rate | 2 | 2014 | 1874 | 0.040 |
Why?
| Minimally Invasive Surgical Procedures | 1 | 2021 | 170 | 0.040 |
Why?
| Canada | 1 | 2021 | 347 | 0.040 |
Why?
| Models, Theoretical | 2 | 2014 | 543 | 0.040 |
Why?
| Vietnam Conflict | 1 | 2020 | 3 | 0.040 |
Why?
| Germ-Line Mutation | 1 | 2021 | 140 | 0.040 |
Why?
| Headache | 1 | 2021 | 150 | 0.040 |
Why?
| Coma | 1 | 2020 | 32 | 0.040 |
Why?
| Behavior Observation Techniques | 1 | 2019 | 9 | 0.040 |
Why?
| Syndrome | 1 | 2020 | 339 | 0.040 |
Why?
| Propensity Score | 1 | 2021 | 265 | 0.040 |
Why?
| Age of Onset | 1 | 2021 | 495 | 0.040 |
Why?
| Defense Mechanisms | 1 | 2019 | 24 | 0.040 |
Why?
| Corneal Edema | 1 | 1999 | 4 | 0.040 |
Why?
| Carbonic Anhydrase Inhibitors | 1 | 1999 | 14 | 0.040 |
Why?
| Single-Cell Analysis | 1 | 2022 | 276 | 0.040 |
Why?
| Fibroblasts | 2 | 2022 | 944 | 0.040 |
Why?
| Gray Matter | 1 | 2020 | 81 | 0.040 |
Why?
| Visual Cortex | 1 | 2020 | 68 | 0.040 |
Why?
| Refractive Errors | 1 | 1999 | 18 | 0.040 |
Why?
| Endothelium, Corneal | 1 | 1999 | 16 | 0.040 |
Why?
| Diplopia | 1 | 2019 | 18 | 0.040 |
Why?
| Basal Ganglia | 1 | 2019 | 53 | 0.040 |
Why?
| Monocytes | 1 | 2022 | 551 | 0.040 |
Why?
| Costs and Cost Analysis | 1 | 2019 | 201 | 0.040 |
Why?
| Cranial Nerve Diseases | 1 | 2019 | 41 | 0.040 |
Why?
| Carotid Artery Diseases | 1 | 2019 | 64 | 0.040 |
Why?
| Cluster Analysis | 1 | 2020 | 481 | 0.040 |
Why?
| Thiophenes | 1 | 1999 | 118 | 0.040 |
Why?
| Polymerase Chain Reaction | 1 | 2021 | 1036 | 0.040 |
Why?
| Symptom Assessment | 1 | 2019 | 125 | 0.040 |
Why?
| Problem Behavior | 1 | 2019 | 92 | 0.040 |
Why?
| Polytetrafluoroethylene | 1 | 1998 | 24 | 0.040 |
Why?
| Dermatologic Surgical Procedures | 1 | 1998 | 18 | 0.040 |
Why?
| Paracentesis | 1 | 2018 | 12 | 0.040 |
Why?
| Postoperative Complications | 2 | 2021 | 2476 | 0.040 |
Why?
| Groin | 1 | 2017 | 10 | 0.040 |
Why?
| Coronary Care Units | 1 | 1998 | 18 | 0.040 |
Why?
| Anterior Cerebral Artery | 1 | 2017 | 5 | 0.040 |
Why?
| Punctures | 1 | 2017 | 40 | 0.040 |
Why?
| Hemorrhage | 1 | 2022 | 677 | 0.040 |
Why?
| Middle Cerebral Artery | 1 | 2017 | 41 | 0.040 |
Why?
| Injections, Intravenous | 1 | 2018 | 201 | 0.040 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 487 | 0.040 |
Why?
| Speech Perception | 1 | 2019 | 82 | 0.030 |
Why?
| Drug Delivery Systems | 1 | 2020 | 335 | 0.030 |
Why?
| Cerebellum | 1 | 2019 | 218 | 0.030 |
Why?
| Random Allocation | 1 | 2018 | 346 | 0.030 |
Why?
| Carotid Artery, External | 1 | 2016 | 3 | 0.030 |
Why?
| Prostheses and Implants | 1 | 1998 | 132 | 0.030 |
Why?
| Parent-Child Relations | 1 | 2019 | 255 | 0.030 |
Why?
| United States | 3 | 2021 | 13873 | 0.030 |
Why?
| Blood Volume | 1 | 2016 | 60 | 0.030 |
Why?
| Amino Acid Sequence | 1 | 2020 | 2056 | 0.030 |
Why?
| Immunosuppressive Agents | 1 | 2021 | 840 | 0.030 |
Why?
| Genetic Variation | 1 | 2021 | 937 | 0.030 |
Why?
| Mental Disorders | 1 | 2024 | 1029 | 0.030 |
Why?
| Gray Platelet Syndrome | 1 | 2015 | 3 | 0.030 |
Why?
| Fibrous Dysplasia, Polyostotic | 1 | 2015 | 7 | 0.030 |
Why?
| Venous Pressure | 1 | 2015 | 8 | 0.030 |
Why?
| Image Enhancement | 1 | 2016 | 163 | 0.030 |
Why?
| Dexamethasone | 1 | 2018 | 346 | 0.030 |
Why?
| Drug Compounding | 1 | 2015 | 97 | 0.030 |
Why?
| Longitudinal Studies | 2 | 2020 | 2713 | 0.030 |
Why?
| Chemotherapy, Adjuvant | 1 | 2016 | 381 | 0.030 |
Why?
| Confidence Intervals | 1 | 1996 | 317 | 0.030 |
Why?
| Sulfonamides | 1 | 1999 | 496 | 0.030 |
Why?
| Sex Distribution | 1 | 1996 | 359 | 0.030 |
Why?
| Diffusion | 1 | 2015 | 117 | 0.030 |
Why?
| Models, Cardiovascular | 1 | 2015 | 191 | 0.030 |
Why?
| Prevalence | 1 | 2021 | 2559 | 0.030 |
Why?
| DNA | 1 | 2021 | 1399 | 0.030 |
Why?
| Particle Size | 1 | 2015 | 355 | 0.030 |
Why?
| Statistics as Topic | 1 | 2015 | 306 | 0.030 |
Why?
| Perfusion | 1 | 2015 | 197 | 0.030 |
Why?
| Biocompatible Materials | 1 | 1998 | 395 | 0.030 |
Why?
| Multimodal Imaging | 1 | 2015 | 109 | 0.030 |
Why?
| Mydriasis | 1 | 2013 | 7 | 0.030 |
Why?
| Clinical Trials as Topic | 1 | 2018 | 1004 | 0.030 |
Why?
| Pandemics | 1 | 2022 | 1477 | 0.030 |
Why?
| Causality | 1 | 2014 | 116 | 0.030 |
Why?
| Electromagnetic Radiation | 1 | 2013 | 2 | 0.030 |
Why?
| Alzheimer Disease | 1 | 2019 | 517 | 0.030 |
Why?
| Benzophenones | 1 | 2013 | 16 | 0.030 |
Why?
| Tissue Distribution | 1 | 2014 | 315 | 0.030 |
Why?
| Glucocorticoids | 1 | 2018 | 574 | 0.030 |
Why?
| Analysis of Variance | 1 | 1996 | 1285 | 0.030 |
Why?
| Breast Neoplasms | 1 | 2025 | 2142 | 0.030 |
Why?
| Oxygen | 1 | 2017 | 911 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 2013 | 282 | 0.030 |
Why?
| California | 1 | 2014 | 401 | 0.020 |
Why?
| Chymases | 1 | 1992 | 4 | 0.020 |
Why?
| Genetic Predisposition to Disease | 1 | 2021 | 2281 | 0.020 |
Why?
| Chromatography, Affinity | 1 | 1992 | 83 | 0.020 |
Why?
| Chromatography, Gel | 1 | 1992 | 127 | 0.020 |
Why?
| Molecular Weight | 1 | 1992 | 331 | 0.020 |
Why?
| Exocytosis | 1 | 1992 | 88 | 0.020 |
Why?
| Inflammation | 1 | 2022 | 2723 | 0.020 |
Why?
| Pilot Projects | 1 | 2016 | 1584 | 0.020 |
Why?
| Pregnancy | 1 | 2022 | 6384 | 0.020 |
Why?
| Blood Loss, Surgical | 1 | 2009 | 91 | 0.020 |
Why?
| Polymers | 1 | 2013 | 479 | 0.020 |
Why?
| Veterans | 1 | 2020 | 1397 | 0.020 |
Why?
| Signal Transduction | 1 | 2021 | 4913 | 0.020 |
Why?
| Disease Progression | 1 | 2015 | 2622 | 0.020 |
Why?
| Carcinoma, Renal Cell | 1 | 2009 | 180 | 0.020 |
Why?
| Incidence | 1 | 2014 | 2638 | 0.020 |
Why?
| Databases, Factual | 1 | 2012 | 1269 | 0.020 |
Why?
| Kidney Neoplasms | 1 | 2009 | 350 | 0.020 |
Why?
| Keratoplasty, Penetrating | 1 | 1999 | 4 | 0.010 |
Why?
| Administration, Topical | 1 | 1999 | 145 | 0.010 |
Why?
| Ophthalmic Solutions | 1 | 1999 | 74 | 0.010 |
Why?
| Evaluation Studies as Topic | 1 | 1998 | 170 | 0.010 |
Why?
| Swine, Miniature | 1 | 1998 | 81 | 0.010 |
Why?
| Equipment Failure | 1 | 1998 | 107 | 0.010 |
Why?
| Electrodes | 1 | 1998 | 103 | 0.010 |
Why?
| Angioplasty, Balloon, Coronary | 1 | 1998 | 140 | 0.010 |
Why?
| Surface Properties | 1 | 1998 | 398 | 0.010 |
Why?
| Intraocular Pressure | 1 | 1999 | 297 | 0.010 |
Why?
| Visual Acuity | 1 | 1999 | 322 | 0.010 |
Why?
| Lymphocytes | 1 | 1998 | 373 | 0.010 |
Why?
| Glaucoma | 1 | 1999 | 219 | 0.010 |
Why?
| Fibrinolytic Agents | 1 | 1998 | 262 | 0.010 |
Why?
| Surgical Wound Infection | 1 | 1998 | 282 | 0.010 |
Why?
| Heart Ventricles | 1 | 1998 | 779 | 0.010 |
Why?
| Neutrophils | 1 | 1998 | 1202 | 0.010 |
Why?
|
|
Cooke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|